Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1075

6'-sialyllactose sodium salt

Intended Use: Intended for use as an ingredient in non-exempt infant formula for term infants at a maximum level of 0.4 g/L. 6?-SL will also be used as an ingredient at a maximum level of 0.3 g/L in beverages and formula for young children (>12 months of age); 2.5 g/kg in foods for infants and young children; 5 g/kg in yogurt; 0.5 g/L in buttermilk and fluid milk (flavored and unflavored); 1 g/L in meal replacement drinks; 10 g/kg in meal replacement bars; 5 g/kg in cereal and granola bars; and 0.5 g/L in soft drinks, fruit-based drinks, sports drinks, energy drinks, and enhanced waters.
Basis: Scientific procedures
Notifier: Inbiose N.V.
Notifier Address: Technologiepark Zwijnaarde 82 bus 41
B-9052 Gent
Belgium
GRAS Notice (releasable information): GRN 1075 with amendments (in PDF) (6.3 MB)
Date of closure: Mar 22, 2023
FDA's Letter: FDA has no questions (in PDF) (286 kB)
-
-